These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24969575)

  • 1. Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetes.
    Gordin D; Forsblom C; Panduru NM; Thomas MC; Bjerre M; Soro-Paavonen A; Tolonen N; Sandholm N; Flyvbjerg A; Harjutsalo V; Groop PH;
    Diabetes Care; 2014 Sep; 37(9):2593-600. PubMed ID: 24969575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status.
    Parente EB; Harjutsalo V; Lehto M; Forsblom C; Sandholm N; Groop PH;
    Cardiovasc Diabetol; 2020 May; 19(1):68. PubMed ID: 32429911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy.
    Hjortebjerg R; Tarnow L; Jorsal A; Parving HH; Rossing P; Bjerre M; Frystyk J
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3032-40. PubMed ID: 26046968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes.
    Tynjälä A; Forsblom C; Harjutsalo V; Groop PH; Gordin D;
    Diabetes Care; 2020 Sep; 43(9):2266-2271. PubMed ID: 32647049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (The FinnDiane Study).
    Gordin D; Wadén J; Forsblom C; Thorn L; Rosengård-Bärlund M; Tolonen N; Saraheimo M; Harjutsalo V; Groop PH;
    Diabetes Care; 2011 Apr; 34(4):886-91. PubMed ID: 21330642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
    Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
    Wadén J; Forsblom C; Thorn LM; Gordin D; Saraheimo M; Groop PH;
    Diabetes; 2009 Nov; 58(11):2649-55. PubMed ID: 19651819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum uric acid predicts cardiovascular mortality in male peritoneal dialysis patients with diabetes.
    Xia X; Zhao C; Peng FF; Luo QM; Zhou Q; Lin ZC; Yu XQ; Huang FX
    Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):20-6. PubMed ID: 26712272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study.
    Nin JW; Ferreira I; Schalkwijk CG; Jorsal A; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
    Diabetologia; 2012 Sep; 55(9):2489-93. PubMed ID: 22752054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality.
    Löwbeer C; Stenvinkel P; Pecoits-Filho R; Heimbürger O; Lindholm B; Gustafsson SA; Seeberger A
    J Intern Med; 2003 Feb; 253(2):153-60. PubMed ID: 12542555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.
    Forsblom C; Moran J; Harjutsalo V; Loughman T; Wadén J; Tolonen N; Thorn L; Saraheimo M; Gordin D; Groop PH; Thomas MC;
    Diabetes Care; 2014 Aug; 37(8):2334-42. PubMed ID: 24879837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S; Hansen TW; Rossing P
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes.
    Harjutsalo V; Thomas MC; Forsblom C; Groop PH;
    Diabetes Obes Metab; 2018 Dec; 20(12):2759-2767. PubMed ID: 29962015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
    Peeters SA; Engelen L; Buijs J; Jorsal A; Parving HH; Tarnow L; Rossing P; Schalkwijk CG; Stehouwer CDA
    Cardiovasc Diabetol; 2017 Apr; 16(1):55. PubMed ID: 28446168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria.
    von Scholten BJ; Reinhard H; Hansen TW; Schalkwijk CG; Stehouwer C; Parving HH; Jacobsen PK; Rossing P
    J Diabetes Complications; 2016 Mar; 30(2):248-55. PubMed ID: 26651261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
    Rossing P; Hougaard P; Borch-Johnsen K; Parving HH
    BMJ; 1996 Sep; 313(7060):779-84. PubMed ID: 8842069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study.
    Jansson FJ; Forsblom C; Harjutsalo V; Thorn LM; Wadén J; Elonen N; Ahola AJ; Saraheimo M; Groop PH;
    Diabetologia; 2018 May; 61(5):1203-1211. PubMed ID: 29423580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.